[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1116735T1 - Αλατα του 1-κυκλοπροπυλ-8-μεθυλ-7-[5-μεθυλ-6-(μεθυλαμινο)-3-πυριδινυλ]-4-οξο-1,4-διυδρο-3-κινολινκαρβοξυλικου οξεος - Google Patents

Αλατα του 1-κυκλοπροπυλ-8-μεθυλ-7-[5-μεθυλ-6-(μεθυλαμινο)-3-πυριδινυλ]-4-οξο-1,4-διυδρο-3-κινολινκαρβοξυλικου οξεος

Info

Publication number
CY1116735T1
CY1116735T1 CY20151100874T CY151100874T CY1116735T1 CY 1116735 T1 CY1116735 T1 CY 1116735T1 CY 20151100874 T CY20151100874 T CY 20151100874T CY 151100874 T CY151100874 T CY 151100874T CY 1116735 T1 CY1116735 T1 CY 1116735T1
Authority
CY
Cyprus
Prior art keywords
methyl
pyridinyl
methylamino
cyclopropyl
dihydro
Prior art date
Application number
CY20151100874T
Other languages
English (en)
Inventor
Albert Palomer
Luis Anglada
Original Assignee
Ferrer Internacional, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional, S.A. filed Critical Ferrer Internacional, S.A.
Publication of CY1116735T1 publication Critical patent/CY1116735T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Παρέχεται ένα άλας του 1-κυκλοπροπυλ-8-μεθυλ-7-[5-μεθυλ-6-(μεθυλαμινο)-3-πυριδινυλ]-4-οξο-1,4-διϋδρο-3-κινολινκαρβοξυλικού οξέος που επιλέγεται από την ομάδα συνιστάμενη από τα άλατα κιτρικό, ημι-φουμαρικό, μηλεϊνικό, L-τρυγικό, μεσυλικό, υδροχλωρικό, καλίου και νατρίου.
CY20151100874T 2010-04-06 2015-09-30 Αλατα του 1-κυκλοπροπυλ-8-μεθυλ-7-[5-μεθυλ-6-(μεθυλαμινο)-3-πυριδινυλ]-4-οξο-1,4-διυδρο-3-κινολινκαρβοξυλικου οξεος CY1116735T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2010/054506 WO2011124249A1 (en) 2010-04-06 2010-04-06 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts
EP10714226.7A EP2556063B1 (en) 2010-04-06 2010-04-06 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts

Publications (1)

Publication Number Publication Date
CY1116735T1 true CY1116735T1 (el) 2017-03-15

Family

ID=42953867

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100874T CY1116735T1 (el) 2010-04-06 2015-09-30 Αλατα του 1-κυκλοπροπυλ-8-μεθυλ-7-[5-μεθυλ-6-(μεθυλαμινο)-3-πυριδινυλ]-4-οξο-1,4-διυδρο-3-κινολινκαρβοξυλικου οξεος

Country Status (19)

Country Link
US (1) US8507684B2 (el)
EP (1) EP2556063B1 (el)
JP (1) JP5836360B2 (el)
KR (1) KR101667089B1 (el)
CN (1) CN102884058B (el)
AU (1) AU2010350521B2 (el)
BR (1) BR112012025475B8 (el)
CA (1) CA2794252C (el)
CY (1) CY1116735T1 (el)
DK (1) DK2556063T3 (el)
ES (1) ES2548989T3 (el)
HK (1) HK1180321A1 (el)
HU (1) HUE026460T2 (el)
MX (1) MX2012011394A (el)
PL (1) PL2556063T3 (el)
PT (1) PT2556063E (el)
RU (1) RU2515557C9 (el)
SI (1) SI2556063T1 (el)
WO (1) WO2011124249A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015166387A (ja) * 2015-06-08 2015-09-24 フエルレル インターナショナル，ソシエダッド アノニマ １‐シクロプロピル‐８‐メチル‐７‐［５‐メチル‐６‐（メチルアミノ）‐３‐ピリジニル］‐４‐オキソ‐１，４‐ジヒドロ‐３‐キノリンカルボン酸塩
CN107121506B (zh) * 2017-04-13 2019-06-07 杭州华东医药集团新药研究院有限公司 奥泽沙星杂质及其用途
WO2020065668A1 (en) * 2018-09-26 2020-04-02 Maithri Drugs Pvt Ltd Crystalline form of ozenoxacin and processes for preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1519529A3 (ru) * 1985-10-29 1989-10-30 Дайниппон Фармасьютикал Ко., Лтд (Фирма) Способ получени производного хинолина, его фармацевтически приемлемого сложного эфира или фармацевтически приемлемой соли производного хинолина или сложного эфира
EP1070713B1 (en) * 1998-04-06 2006-10-18 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
JP4293755B2 (ja) 2001-03-26 2009-07-08 富山化学工業株式会社 ピリドンカルボン酸系化合物を含有する皮膚外用剤
JP4384402B2 (ja) 2001-11-30 2009-12-16 富山化学工業株式会社 デスフルオロピリドンカルボン酸系化合物を含有する水溶液剤およびその粉末化物並びにそれら製造方法
ES2566486T3 (es) 2004-03-31 2016-04-13 Toyama Chemical Co., Ltd. Dispersión fina de fármaco moderadamente soluble y proceso de producción de la misma
CN101272786B (zh) * 2005-08-01 2011-05-04 丸宝株式会社 含有吡啶酮羧酸衍生物的洗剂
JP5112669B2 (ja) 2005-09-30 2013-01-09 富山化学工業株式会社 難溶性薬物のナノ微粒子を含有する水性懸濁液剤

Also Published As

Publication number Publication date
SI2556063T1 (sl) 2015-10-30
CN102884058B (zh) 2014-08-20
RU2515557C9 (ru) 2014-06-27
EP2556063B1 (en) 2015-07-01
ES2548989T3 (es) 2015-10-22
HK1180321A1 (en) 2013-11-29
WO2011124249A1 (en) 2011-10-13
KR101667089B1 (ko) 2016-10-17
KR20130039316A (ko) 2013-04-19
EP2556063A1 (en) 2013-02-13
PL2556063T3 (pl) 2015-12-31
MX2012011394A (es) 2012-11-29
CN102884058A (zh) 2013-01-16
AU2010350521A1 (en) 2012-11-01
BR112012025475B8 (pt) 2021-05-25
RU2515557C1 (ru) 2014-05-10
BR112012025475B1 (pt) 2021-04-27
US8507684B2 (en) 2013-08-13
JP2013523786A (ja) 2013-06-17
US20130040989A1 (en) 2013-02-14
HUE026460T2 (en) 2016-05-30
BR112012025475A8 (pt) 2017-10-17
DK2556063T3 (en) 2015-09-28
CA2794252C (en) 2015-06-23
PT2556063E (pt) 2015-10-22
CA2794252A1 (en) 2011-10-13
BR112012025475A2 (pt) 2016-06-21
AU2010350521B2 (en) 2015-04-16
JP5836360B2 (ja) 2015-12-24

Similar Documents

Publication Publication Date Title
NL301201I2 (nl) Asciminib of een farmaceutisch aanvaardbaar zout daarvan, zoals asciminibhydrochloride
NO2018036I1 (no) Kombinasjon omfattende dolutegravlr eller et farrmasøytisk akseptabelt salt derav (feks dolutegravirnatrium) og rilpivirin eller et farrmasøytisk akseptabelt salt derav (for eksempel ilpivirinhydrokllorid)
NL300947I2 (nl) Bictegravir of een farmaceutisch aanvaardbaar zout daarvan, in het bijzonder bictegravirnatrium
CY1120832T1 (el) Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
NO20093146L (no) Amino-pyridinderivater som S1P1/EDG1-reseptoragonister
CY1118678T1 (el) Παραγωγα καρβοξαμιδιου χλωρο-πυραζινης χρησιμα για την θεραπευτικη αντιμετωπιση ασθενειων που ευνοουνται απο την ανεπαρκη ενυδατωση του βλεννογονου
BR112015000704A2 (pt) imidazotriazinacarbonitrilas úteis como inibidores de quinase
HK1216173A1 (zh) -芳基取代的和 -雜芳基取代的 -羥基吡啶- -基-羰基氨基-鏈烷酸及其衍生物和其鹽，以及用相應 -羥基吡啶甲酸的衍生物進行製備的方法
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
SMT201200014B (it) Nalmefene cloridrato diidrato.
IN2014DN10670A (el)
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
UA115357C2 (uk) Похідні піридин-4-ілу
WO2014192030A3 (en) An improved process for preparation of dabigatran etexilate and pharmaceutically acceptable acid addition salts thereof
JO2889B1 (en) Salts 6N - (CIS-2, 6-dimethyl morpholine-4-yl) pyridine-3-yl-methyl-4 ’- (tetrafluoromethoxy) [1,1,-2-phenyl] -3-carboxamide
ZA202200511B (en) Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis
UA104420C2 (uk) Застосування похідних глутарової кислоти або їх фармацевтично прийнятних солей як протиаритмічних засобів
EA201492029A1 (ru) N-этил-4-гидроксил-1-метил-5-(метил(2,3,4,5,6-пентагидроксигексил)амино)-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид
CY1116735T1 (el) Αλατα του 1-κυκλοπροπυλ-8-μεθυλ-7-[5-μεθυλ-6-(μεθυλαμινο)-3-πυριδινυλ]-4-οξο-1,4-διυδρο-3-κινολινκαρβοξυλικου οξεος
PL408073A1 (pl) Chwastobójczy koncentrat zawiesinowy
PH12015500399A1 (en) Azaindolines
UA109804C2 (xx) 2-метоксипіридин-4-ільні похідні
JP2013535391A5 (el)
MX2016008729A (es) Composicion farmaceutica que contiene clomipramina y metodo de preparacion de la misma.